WILLIAM WONG to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications WILLIAM WONG has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
1.432
-
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada. Curr Oncol. 2024 Dec 27; 32(1).
Score: 0.692
-
A Systematic Review of the Cost-Effectiveness Analyses of Anaplastic Lymphoma Kinase (ALK) Inhibitors in Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC). Pharmacoeconomics. 2023 08; 41(8):945-980.
Score: 0.621
-
Impact of Spot Size and Spacing on the Quality of Robustly Optimized Intensity Modulated Proton Therapy Plans for Lung Cancer. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):479-489.
Score: 0.107
-
Analgesic effect of electroacupuncture in postthoracotomy pain: a prospective randomized trial. Ann Thorac Surg. 2006 Jun; 81(6):2031-6.
Score: 0.012